Airja is an intellectual property, and product development company, that commercializes and licenses, novel respiratory drug delivery technology in both pharmaceutical markets, and recreational markets (nicotine, cannabinoids). Currently, Airja is investigating many pharmaceutical compounds and indications of potential products. Additionally, Airja has a business unit commercializing products in the cannabinoid space.